Skip to main content
OpenTrials

Clinical trial condition

Leukemia, T-Cell

Explore clinical trials studying Leukemia, T-Cell. Study availability and eligibility vary by location and protocol.

144 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, T-Cell trial results

Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

NCT05010005

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • University of Miami (Data Collection Only) Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

NCT03719105

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Children's Hospital Orange County Orange, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Helen De Vos Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Registry of Older Patients With Cancer

NCT01137825

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • East Carolina University Greenville, North Carolina, United States
  • Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details
Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

NCT05475925

Conditions
Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
Locations
  • Dren Investigational Site Birmingham, Alabama, United States
  • Dren Investigational Site Duarte, California, United States
  • Dren Investigational Site Irvine, California, United States
  • Dren Investigational Site Redwood City, California, United States
View all 37 locations
View Trial Details

Related conditions